Jae-Sung Yi Selected Research

Long Noncoding RNA

10/2013

The imprinted H19 lncRNA antagonizes let-7 microRNAs.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jae-Sung Yi Research Topics

Disease

4	Fibrosis (Cirrhosis) 01/2022 - 12/2016
3	Neoplasms (Cancer) 10/2013 - 07/2011
2	Non-alcoholic Fatty Liver Disease 07/2023 - 01/2023
2	Inborn Genetic Diseases (Disease, Hereditary) 01/2020 - 10/2013
2	Noonan Syndrome (Female Pseudo-Turner Syndrome) 02/2017 - 12/2016
1	LEOPARD Syndrome (Syndrome, LEOPARD) 01/2022
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/2017
1	Cardiomyopathies (Cardiomyopathy) 12/2016
1	Mitochondrial complex I deficiency 07/2014
1	Insulin Resistance 01/2013
1	Neoplasm Metastasis (Metastasis) 07/2011

Drug/Important Bio-Agent (IBA)

2	Caspase 6IBA 07/2023 - 01/2023
2	AMP-Activated Protein KinasesIBA 07/2023 - 01/2023
2	Adenosine Monophosphate (AMP)IBA 07/2023 - 01/2023
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 12/2016
2	Insulin (Novolin)FDA Link 07/2014 - 01/2013
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 02/2017
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 02/2017
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 02/2017
1	Therapeutic UsesIBA 02/2017
1	Sirtuin 1IBA 07/2014
1	MicroRNAs (MicroRNA)IBA 10/2013
1	Long Noncoding RNAIBA 10/2013
1	LipidsIBA 02/2013
1	Detergents (Detergent)IBA 02/2013
1	Sucrose (Saccharose)IBA 01/2013
1	Complement System Proteins (Complement)IBA 07/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 07/2011
1	Cell Surface ReceptorsIBA 07/2011

Therapy/Procedure

1	Therapeutics 12/2016